Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ACRX - AcelRx stock falls 15% after HC Wainwright downgrade on 'disappointing quarter'

ACRX - AcelRx stock falls 15% after HC Wainwright downgrade on 'disappointing quarter'

AcelRx Pharmaceuticals Inc.
AcelRx Pharmaceuticals (ACRX -15.1%) was downgraded by H.C. Wainwright to Neutral from Buy without a price target following its Q4 results last week. The company lost -20.64% on March 11, the day after its Q4 results on March 10 post market. Analyst Ed Arce said the company reported "another disappointing quarter, punctuated by the poor optics of the top-line number." AcelRx (NASDAQ:ACRX) Q4 total revenue declined to $2K, compared to $738K in Q4 2020. The company had said that it recognized only $2K in net revenues in Q4 due to a $0.3M reserve for potential returns.

For further details see:

AcelRx stock falls 15% after HC Wainwright downgrade on 'disappointing quarter'
Stock Information
Company Name: AcelRx Pharmaceuticals Inc.
Stock Symbol: ACRX
Market: NASDAQ
Website: acelrx.com
Menu
ACRX ACRX Quote ACRX Short ACRX News ACRX Articles ACRX Message Board
Get ACRX Alerts

News, Short Squeeze, Breakout and More Instantly...